PAPST1, formally recognized as 3'-phosphoadenosine 5'-phosphosulfate transporter 1, is crucial in the sulfation pathway, a fundamental cellular process responsible for the sulfation of various molecules, including hormones, proteins, and lipids. This transporter facilitates the movement of 3'-phosphoadenosine 5'-phosphosulfate (PAPS) from the cytosol, where it is synthesized, to the Golgi apparatus. In the Golgi, PAPS serves as the essential sulfonate donor for sulfotransferase enzymes, which, in turn, modify acceptor molecules through sulfation. This modification is vital for numerous biological activities such as detoxification, modulation of hormone activity, and the regulation of molecular recognition and signaling pathways. As such, PAPST1 plays a significant role in ensuring that sulfation, a process integral to cellular communication and the maintenance of homeostasis, proceeds efficiently within the cell.
The activation of PAPST1 is crucial for the enhancement of the sulfation capacity within cells, directly influencing the efficiency and efficacy of cellular processes that rely on sulfated molecules. Activation mechanisms could encompass various strategies, such as the upregulation of PAPST1 expression, promoting a greater abundance of the transporter available for PAPS movement. Alternatively, post-translational modifications of PAPST1 that enhance its affinity for PAPS or its transport efficiency could significantly increase sulfation activity. Such modifications might include phosphorylation or acetylation, which can alter the transporter's conformation in a manner that favors PAPS binding and transport. Furthermore, the cellular localization of PAPST1 could be dynamically regulated to ensure optimal interaction with sulfotransferases in the Golgi apparatus, thereby facilitating a more efficient sulfation process. Through these mechanisms, the activation of PAPST1 underscores the adaptability and regulation of cellular pathways to meet the demands of the organism, highlighting the importance of precise control mechanisms in the maintenance of cellular and systemic homeostasis.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels. Elevated cAMP can enhance the activity of PAPST1 by promoting a cellular environment that favors sulfonation reactions, the primary function of PAPST1. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX increases intracellular cAMP by inhibiting phosphodiesterases. Higher cAMP levels can stimulate the activity of PAPST1 by inducing a favorable state for its sulfotransferase activity. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram inhibits phosphodiesterase 4, leading to increased cAMP levels. An increase in cAMP can facilitate the sulfonation activity of PAPST1 as part of its normal cellular function. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine stimulates adenylate cyclase via beta-adrenergic receptors, increasing cAMP. Higher cAMP can enhance the sulfonation activity of PAPST1 by optimizing the cellular context for its function. | ||||||
PACAP(6-38) | 137061-48-4 | sc-391136 sc-391136A | 500 µg 1 mg | $540.00 $932.00 | ||
PACAP activates adenylate cyclase through its receptor, increasing cAMP levels. This can indirectly lead to the functional activation of PAPST1 by enhancing the sulfonation processes it mediates. | ||||||
Adenosine | 58-61-7 | sc-291838 sc-291838A sc-291838B sc-291838C sc-291838D sc-291838E sc-291838F | 1 g 5 g 100 g 250 g 1 kg 5 kg 10 kg | $34.00 $48.00 $300.00 $572.00 $1040.00 $2601.00 $4682.00 | 1 | |
Adenosine activates adenylate cyclase through the A2A receptor, raising cAMP levels. Increased cAMP can contribute to the activation of PAPST1 by facilitating the sulfonation reactions within its action scope. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP, a cAMP analog, directly elevates cAMP levels intracellularly, potentially facilitating the sulfonation activity of PAPST1 by mimicking the effect of endogenous cAMP. | ||||||
Sp-cAMPS | 93602-66-5 | sc-201571 | 1 mg | $97.00 | 3 | |
Sp-cAMPS, a cAMP analog resistant to degradation, maintains high cAMP levels, potentially supporting the sulfotransferase function of PAPST1 in cellular sulfonation reactions. | ||||||
Aminophylline | 317-34-0 | sc-252368 | 25 g | $37.00 | ||
Aminophylline inhibits phosphodiesterases, leading to increased cAMP levels, which could indirectly activate PAPST1 by enhancing the cellular processes that require its sulfotransferase activity. | ||||||
Papaverine | 58-74-2 | sc-279951 sc-279951A sc-279951B | 10 mg 50 mg 100 mg | $153.00 $265.00 $459.00 | ||
Papaverine, a phosphodiesterase inhibitor, elevates cAMP levels, potentially facilitating PAPST1 activity by augmenting the cellular conditions that are conducive to its sulfotransferase action. | ||||||